Results 61 to 70 of about 2,747 (207)
Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population. [PDF]
BACKGROUND: Little evidence is available to determine which patients should undergo repeat biopsy after initial benign extended core biopsy (ECB). Attempts have been made to reduce the frequency of negative repeat biopsies using PSA kinetics, density ...
Doble, Andrew +4 more
core
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression [PDF]
Background PTOV1 is an adaptor protein with functions in diverse processes, including gene transcription and protein translation, whose overexpression is associated with a higher proliferation index and tumor grade in prostate cancer (PC) and other ...
Abasolo, Ibane +15 more
core +1 more source
Abstract Background This study explored the value of intraductal carcinoma of the prostate (IDC‐P) in predicting the efficacy of abiraterone treatment in metastatic hormone‐sensitive prostate cancer (mHSPC) patients. Methods A retrospective study of 925 patients who underwent prostate biopsies to detect IDC‐P was conducted, with participants divided ...
Xinyuan Wei +14 more
wiley +1 more source
The value of touch imprint cytology of prostate core needle biopsy specimens – Kuwait experience
Objectives: Touch imprint cytology (TIC) is a reliable, cost-effective technique for the diagnosis of cancer. The aim of this study was to determine the diagnostic value and accuracy of TIC of prostate core needle biopsy (CNB) specimens in predicting the
S. Hussein +4 more
doaj +1 more source
DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications
ABSTRACT Background Prostate cancer is a common cancer with a variable prognosis. Its management is currently guided by histological and biological markers such as the Gleason score and PSA. Developments in molecular biology are now making it possible to identify new targets for better classification of prostate cancer.
Romane Muletier +3 more
wiley +1 more source
Najla Aldaoud,1,2 Ashley Graboski-Bauer,3 Nour Abdo,4 Samir Al Bashir,1,2 Ashraf O Oweis,5 Hanadi Ebwaini,1 Yousef Hasen,1–2,6 Rami Alazab,7 Kiril Trpkov81Department of Pathology and Microbiology, King Abdullah University Hospital, Irbid, Jordan ...
Aldaoud N +8 more
doaj
Purpose We report our experience on metformin use in diabetic patients and its impact on prostate cancer (PCa) after a high-grade prostatic intraepithelial neoplasia (HGPIN) diagnosis.
Lucio Dell'Atti, Andrea B. Galosi
doaj +1 more source
Background: We investigated the correlation between the sampled number of cores in rebiopsy and the cancer detection rate (CDR). Materials and Methods: Two hundred and twelve patients with normal rectal examination who had undergone rebiopsy in the past ...
Akın Soner Amasyali +7 more
doaj +1 more source
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity [PDF]
Background The serine/threonine kinase PIM1 has been implicated as an oncogene in various human cancers including lymphomas, gastric, colorectal and prostate carcinomas.
Jongchan Kim +48 more
core +1 more source
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre [PDF]
Objective To investigate the clinical and pathological trends over a ten-year period for robotic-assisted laparoscopic prostatectomy (RALP) in a UK regional tertiary referral centre.
Gnanapragasam, Vincent +14 more
core +1 more source

